OBJECTIVE: To improve mechanistic understanding, this pilot randomized controlled trial examined mediators of an exercise intervention effects on sleep in breast cancer survivors (BCS). METHODS:Forty-six postmenopausal BCS (≤Stage II, off primary treatment) were randomized to a 3-month exercise intervention or control group. Intervention included 160 min/week of moderate intensity aerobic walking, twice weekly resistance training (resistance bands), and six discussion groups (to improve adherence). Blinded assessments at baseline and post-intervention included sleep disturbance (PSQI and PROMIS®), objective sleep quality (accelerometer), serum cytokines, accelerometer physical activity, cardiorespiratory fitness, body composition, fatigue, and psychosocial factors. Mediation was tested using Freedman-Schatzkin difference-in-coefficients tests. RESULTS: When compared with control, the intervention group demonstrated a significant increase in PSQI sleep duration (i.e., fewer hours of sleep/night) (d = 0.73, p = .03). Medium to large but non-significant standardized effect sizes were noted for PSQI daytime somnolence (d = -0.63, p = .05) and accelerometer latency (d = -0.49, p = .14). No statistically significant mediators were detected for PSQI sleep duration score or accelerometer latency. Daytime somnolence was mediated by tumor necrosis factor-alpha (mediated 23% of intervention effect, p < .05), interleukin (IL)-6:IL-10 (16%, p < .01), IL-8:IL-10 (26%, p < .01), and fatigue (38%, p < .05). Mediating or enhancing relationships for several of the sleep outcomes were noted for accelerometer physical activity, PROMIS® fatigue, exercise social support, and/or physical activity enjoyment. CONCLUSIONS: Inflammation and psychosocial factors may mediate or enhance sleep response to our exercise intervention. Further study is warranted to confirm our results and translate our findings into more effective interventions aimed at improving sleep quality in BCS.
RCT Entities:
OBJECTIVE: To improve mechanistic understanding, this pilot randomized controlled trial examined mediators of an exercise intervention effects on sleep in breast cancer survivors (BCS). METHODS: Forty-six postmenopausal BCS (≤Stage II, off primary treatment) were randomized to a 3-month exercise intervention or control group. Intervention included 160 min/week of moderate intensity aerobic walking, twice weekly resistance training (resistance bands), and six discussion groups (to improve adherence). Blinded assessments at baseline and post-intervention included sleep disturbance (PSQI and PROMIS®), objective sleep quality (accelerometer), serum cytokines, accelerometer physical activity, cardiorespiratory fitness, body composition, fatigue, and psychosocial factors. Mediation was tested using Freedman-Schatzkin difference-in-coefficients tests. RESULTS: When compared with control, the intervention group demonstrated a significant increase in PSQI sleep duration (i.e., fewer hours of sleep/night) (d = 0.73, p = .03). Medium to large but non-significant standardized effect sizes were noted for PSQI daytime somnolence (d = -0.63, p = .05) and accelerometer latency (d = -0.49, p = .14). No statistically significant mediators were detected for PSQI sleep duration score or accelerometer latency. Daytime somnolence was mediated by tumor necrosis factor-alpha (mediated 23% of intervention effect, p < .05), interleukin (IL)-6:IL-10 (16%, p < .01), IL-8:IL-10 (26%, p < .01), and fatigue (38%, p < .05). Mediating or enhancing relationships for several of the sleep outcomes were noted for accelerometer physical activity, PROMIS® fatigue, exercise social support, and/or physical activity enjoyment. CONCLUSIONS:Inflammation and psychosocial factors may mediate or enhance sleep response to our exercise intervention. Further study is warranted to confirm our results and translate our findings into more effective interventions aimed at improving sleep quality in BCS.
Authors: Lisa K Sprod; Oxana G Palesh; Michelle C Janelsins; Luke J Peppone; Charles E Heckler; M Jacob Adams; Gary R Morrow; Karen M Mustian Journal: Community Oncol Date: 2010-10
Authors: Nicola Cellini; Matthew P Buman; Elizabeth A McDevitt; Ashley A Ricker; Sara C Mednick Journal: Chronobiol Int Date: 2013-05-30 Impact factor: 2.877
Authors: Kristine A Donovan; Paul B Jacobsen; Brent J Small; Pamela N Munster; Michael A Andrykowski Journal: J Pain Symptom Manage Date: 2008-05-20 Impact factor: 3.612
Authors: Shiraz I Mishra; Roberta W Scherer; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu; Carolyn C Gotay; Claire Snyder Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner Journal: J Proteome Res Date: 2009-01 Impact factor: 4.466
Authors: Elizabeth Ann Coleman; Julia A Goodwin; Robert Kennedy; Sharon K Coon; Kathy Richards; Carol Enderlin; Carol B Stewart; Paula McNatt; Kim Lockhart; Elias J Anaissie Journal: Oncol Nurs Forum Date: 2012-09 Impact factor: 2.172
Authors: Laura Q Rogers; Kerry S Courneya; Robert A Oster; Philip M Anton; Randall S Robbs; Andres Forero; Edward McAuley Journal: Med Sci Sports Exerc Date: 2017-10 Impact factor: 5.411
Authors: Christina M Dieli-Conwright; Kerry S Courneya; Wendy Demark-Wahnefried; Nathalie Sami; Mary K Norris; Frank S Fox; Thomas A Buchanan; Darcy Spicer; Leslie Bernstein; Debu Tripathy Journal: Sleep Date: 2021-10-11 Impact factor: 5.849
Authors: Joshua Bauml; Lu Chen; Jinbo Chen; Jean Boyer; Michael Kalos; Susan Q Li; Angela DeMichele; Jun J Mao Journal: Breast Cancer Res Date: 2015-06-28 Impact factor: 6.466
Authors: Wanderson Divino Nilo Dos Santos; Paulo Gentil; Rafael Felipe de Moraes; João Batista Ferreira Júnior; Mário Hebling Campos; Claudio Andre Barbosa de Lira; Ruffo Freitas Júnior; Martim Bottaro; Carlos Alexandre Vieira Journal: Biomed Res Int Date: 2017-08-01 Impact factor: 3.411
Authors: Hannah M Fisher; Joseph G Winger; Shannon N Miller; Arianna N Wright; Jennifer C Plumb Vilardaga; Catherine Majestic; Sarah A Kelleher; Tamara J Somers Journal: Support Care Cancer Date: 2021-03-15 Impact factor: 3.603
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19
Authors: Jojanneke A M C van Kooten; Caroline B Terwee; Gertjan J L Kaspers; Raphaёle R L van Litsenburg Journal: Health Qual Life Outcomes Date: 2016-06-18 Impact factor: 3.186